Lee Ainslie’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
WA
Lee Ainslie's RGEN Position: Q2 2026 in Review
Lee Ainslie increased its Repligen (RGEN) stake by 31% in Q2 2026, buying an estimated $57.2M and bringing the position to 1,984,554 shares worth $271M. The position accounts for 2.39% of the portfolio, ranked #16.
Lee Ainslie first reported a position in RGEN in Q1 2021 and has held it in 3 quarters since. 476 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Lee Ainslie held 1,984,554 shares of Repligen worth $271M as of Q2 2026.
- Lee Ainslie bought 465,749 Repligen shares in Q2 2026, an estimated $57.2M.
- Repligen made up 2.39% of Lee Ainslie's portfolio in Q2 2026, its #16 holding.
- Lee Ainslie first reported a position in Repligen in Q1 2021 and has held it in 3 quarters since.
- 476 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.